- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 93,750 | 22.07.24 16:25:45 | +1,680 | +1,82% | 93,540 | 93,550 | 92,940 | 92,070 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 970,000 | 22.07.24 11:57:26 | -12,400 | -1,26% | 980,600 | 986,200 | 972,000 | 982,400 |
